At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
Renal Denervation (Symplicity® Renal Denervation System)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)
In Brief
A clinical study evaluating Renal Denervation (Symplicity® Renal Denervation System) for Uncontrolled Hypertension. Completed, enrolled 106 participants across 20 sites in 10 countries.
Detailed Summary
An international, multi-center, prospective, randomized, controlled study of the safety and effectiveness of renal denervation in patients with uncontrolled hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUncontrolled Hypertension
CountriesAustralia, Austria, Belgium, France, Germany, Latvia, Poland, Spain, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2009
Enrollment StartJun 2009
Primary CompletionSep 2010
Study CompletionMay 2015
TodayJul 2026
First PostedApr 27, 2009
Enrollment StartJun 1, 2009
Primary CompletionSep 1, 2010
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.2 years ago
Interventions
Renal Denervation (Symplicity® Renal Denervation System)device
Catheter-based renal denervation